ViaCyte Competitors and Similar CompaniesClear all
Profil's competitors and similar companies include KalVista Pharmaceuticals and Kerecis.
 Profil Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity. |  KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME). |  Kerecis Kerecis develops, manufactures and markets patented Omega3 rich fish skin, in skin and tissue repair. | |
Founding Date | Founding Date 1999 | Founding Date 2011 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Neuss, DE HQ Mainz, DE | Locations Porton Down, GB HQ Cambridge, US | Locations Arlington, US HQ Ísafjörður, IS Reykjavík, IS Reykjavík, IS |
Employees | Employees 200 | Employees 150 | Employees 512 |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 46.2m | Total funding raised $ 27.6m |
For sources of this data, please see the company profile
View Company Profiles
KalVista Pharmaceuticals
HQ
Porton Down, GB
Employees
150
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
View companyKerecis
HQ
Arlington, US
Employees
512
Kerecis develops, manufactures and markets patented Omega3 rich fish skin, in skin and tissue repair.
View company